Can bioinformatics point the way towards a universal flu vaccine?

Steve Keen talks to us about Trump, China, free trade and globalization

Experts discuss the trends and challenges in the development of complex dosage forms.

Are you up-to-date with new analytical platforms that can give you the edge?

The players and chips are ready, what can poker teach us about the biosimilars business?

Big pharma CEOs should be wary of because orphans are usually better off alone.

Manufacturing specialists must develop cell therapy factories that can meet high demands.

Sitting Down With... Carol Lynch, Global Head Biopharmaceuticals, Sandoz.

A universal flu vaccine is not impossible for the industry – we just need bioinformatics.

Tablets are the most common dosage form, but have you considered all of your options?